We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCR
126
DELISTED
CR Bard Inc.
BCR
| $14.5M | 0.24% |
98,142
-34,260
| -26% | -$4.74M |
|
127
Andersons Inc
ANDE
$2.65B
| $14.5M | 0.24% |
244,072
-11,545
| -5% | -$646K |
|
|
FITB
128
Fifth Third Bancorp
FITB
$52B
| $14.4M | 0.24% |
+625,690
| New | +$13.6M |
|
129
HCA Healthcare
HCA
$84.8B
| $14.2M | 0.24% |
269,860
+163,260
| +153% | +$8.12M |
|
|
STI
130
DELISTED
SunTrust Banks, Inc.
STI
| $14.1M | 0.24% |
354,100
+298,800
| +540% | +$11.4M |
|
131
Caterpillar
CAT
$409B
| $13.9M | 0.23% |
140,130
+96,580
| +222% | +$9.11M |
|
132
Ryder
R
$10.3B
| $13.7M | 0.23% |
171,984
-11,690
| -6% | -$866K |
|
133
Verizon
VZ
$194B
| $13.6M | 0.23% |
286,540
+274,130
| +2,209% | +$13M |
|
134
Manhattan Associates
MANH
$8.97B
| $13.4M | 0.22% |
381,794
+308,294
| +419% | +$10.7M |
|
|
LVLT
135
DELISTED
Level 3 Communications Inc
LVLT
| $13.3M | 0.22% |
+339,826
| New | +$12.2M |
|
136
Cisco
CSCO
$450B
| $13.2M | 0.22% |
587,920
-1,315,010
| -69% | -$29.1M |
|
137
Allstate
ALL
$66.9B
| $12.9M | 0.22% |
228,560
-4,890
| -2% | -$262K |
|
138
Medtronic
MDT
$107B
| $12.8M | 0.22% |
208,790
-6,599
| -3% | -$384K |
|
|
XEC
139
DELISTED
CIMAREX ENERGY CO
XEC
| $12.7M | 0.21% |
106,721
+64,828
| +155% | +$6.96M |
|
140
Steel Dynamics
STLD
$35.6B
| $12.7M | 0.21% |
711,110
+248,080
| +54% | +$4.34M |
|
141
Moody's
MCO
$81.7B
| $12.6M | 0.21% |
159,157
-302,323
| -66% | -$23.7M |
|
|
WLL
142
DELISTED
Whiting Petroleum Corporation
WLL
| $12.6M | 0.21% |
606
-129
| -18% | -$2.44M |
|
143
HUB Group
HUBG
$3.01B
| $12.5M | 0.21% |
624,966
-115,700
| -16% | -$2.34M |
|
|
RDC
144
DELISTED
Rowan Companies Plc
RDC
| $12.2M | 0.2% |
362,900
-168,910
| -32% | -$5.52M |
|
145
ON Semiconductor
ON
$33.8B
| $12.1M | 0.2% |
1,287,723
+1,231,723
| +2,200% | +$11.1M |
|
|
SIVB
146
DELISTED
SVB Financial Group
SIVB
| $12.1M | 0.2% |
93,678
+33,095
| +55% | +$3.87M |
|
147
Zimmer Biomet
ZBH
$17.7B
| $12.1M | 0.2% |
131,304
-3,647
| -3% | -$336K |
|
148
Celanese
CE
$5.09B
| $11.8M | 0.2% |
+213,046
| New | +$11.3M |
|
149
Reliance Steel & Aluminium
RS
$20.8B
| $11.8M | 0.2% |
167,042
+138,512
| +485% | +$9.88M |
|
150
Booz Allen Hamilton
BAH
$8.7B
| $11.8M | 0.2% |
535,076
+25,299
| +5% | +$505K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.